Drug-eluting coronary stents

Curr Probl Cardiol. 2006 Jan;31(1):8-119. doi: 10.1016/j.cpcardiol.2005.09.002.

Abstract

The introduction and widespread use of coronary stents have been the most important advancement in the percutaneous treatment of coronary artery disease since the introduction of balloon angioplasty. Coronary artery stents reduce the rate of angiographic and clinical restenosis compared to balloon angioplasty. This angiographic restenosis was further reduced with the introduction of drug-eluting stents and hence further reduction in the frequency of major adverse cardiac events. Herein we present a comprehensive and up-to-date review about the use of drug-eluting stents in the treatment of coronary artery disease.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage
  • Antineoplastic Agents / administration & dosage
  • Cardiovascular Agents / administration & dosage
  • Clinical Trials as Topic
  • Coronary Restenosis / physiopathology
  • Coronary Restenosis / prevention & control*
  • Drug Delivery Systems*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Prosthesis Design
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
  • Stents*

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Cardiovascular Agents
  • Immunosuppressive Agents
  • Receptor Protein-Tyrosine Kinases